Title : Improving outcomes in advanced malignant melanoma: update on systemic therapy.

Pub. Date : 2005

PMID : 15819587






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The BRaf inhibitor sorafenib (BAY 43-9006) has produced encouraging results when administered with chemotherapy and is now being assessed in randomised studies. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens
2 The BRaf inhibitor sorafenib (BAY 43-9006) has produced encouraging results when administered with chemotherapy and is now being assessed in randomised studies. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens